2650550-87-9
Chemical Structure
KRAS G12C inhibitor 35
- CAS No.: 2650550-87-9
- Formula:C31H27ClF2N6O3
- Molecular Weight:605.03
IUPAC Name: 4-(4-acryloylpiperazin-1-yl)-7-(3-chloro-2-fluoro-6-hydroxyphenyl)-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carbonitrile
InChIKey: VKOUGWHSWXDAGP-UHFFFAOYSA-N
SMILES: N#CC1=C(N2CCN(C(C=C)=O)CC2)C3=C(N(C4=C(C)C=CN=C4C(C)C)C1=O)N=C(C5=C(O)C=CC(Cl)=C5F)C(F)=C3
Biological Activity: KRAS G12C inhibitor 35 is a potent inhibitor of KRAS G12C. The Ras family of proteins is an important intracellular signaling molecule that plays an important role in growth and development. KRAS G12C inhibitor 35 has the potential for the research of KRAS G12C-mediated cancer (extracted from patent CN112920183A, compound 3)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
KRAS G12C inhibitor 35 | KRAS G12C inhibitor 35 is a potent inhibitor of KRAS G12C. The Ras family of proteins is an important intracellular signaling molecule that plays an important role in growth and development. KRAS G12C inhibitor 35 has the potential for the research of KRAS G12C-mediated cancer (extracted from patent CN112920183A, compound 3). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
